NORDIC BIOTECH INCENTIVE ApS: Financial statements 2023
CVR: 26277779
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
NORDIC BIOTECH INCENTIVE ApS (CVR 26277779) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 133,444 and a net result of DKK -35,522 compared with DKK -2,261,727 the year before. Equity in the 2023 report amounted to DKK 1,682,934. The solvency ratio was 97.4%.
- Gross Profit
- DKK 133,444
- Profit/Loss
- DKK -35,522
- Equity
- DKK 1,682,934
- Total Assets
- DKK 1,727,809
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 133K | -36K | 1.7M | - |
| 2022 | - | -18K | -2.3M | 1.7M | 0 |
| 2021 | - | -15K | -338K | 4M | 0 |
| 2020 | - | -17K | -87K | 4.3M | - |
| 2019 | - | -29K | 624K | 4.4M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2022. Gross profit came to DKK -17,993, and the net result was DKK -2,261,727.
About NORDIC BIOTECH INCENTIVE ApS
NORDIC BIOTECH INCENTIVE ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company has been dissolved on 30 September 2026. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -397,188 and a net result of DKK -719,666 compared with DKK 4,871,034 the year before. Equity in the 2025 report amounted to DKK 5,834,302.